Semaglutide Explained: What It Is, Who It's For, and What Patients Should Know

If you've been anywhere near a health headline in the last two years, you've probably seen the word semaglutide. Celebrities mention it. Doctors debate it. Friends whisper about it at dinner parties.

But behind the hype is a real medicine with real science — one that has changed how doctors think about both diabetes and obesity. It's not a fad diet pill. It's not a shortcut. It's a prescription medication that works with your body's own hormones to help regulate blood sugar and appetite.

In this post, we'll break it all down: what semaglutide actually is, how it works, which brand names you might recognise, who it's designed for, and what patients in India should know before considering it.

Semaglutide is a medicine — specifically, a molecule created in a lab that mimics a hormone your body already makes. That hormone is called GLP-1, which stands for glucagon-like peptide-1.

Here's the simple version: every time you eat, your gut releases GLP-1. This hormone does a few important things:

• It tells your pancreas to release insulin, which helps lower blood sugar.
• It signals your brain that you're getting full, so you naturally want to stop eating.
• It slows down how fast food leaves your stomach, so you feel satisfied for longer.

The problem? Natural GLP-1 breaks down in your body within minutes. It does its job and disappears almost immediately.

Semaglutide is engineered to last much, much longer — up to about a week. Think of it like this: if natural GLP-1 is a text message that vanishes after being read, semaglutide is the same message pinned to the top of your phone for seven days. The signal stays active, and your body keeps responding to it.

This extended action is what makes semaglutide so effective. It belongs to a class of drugs called GLP-1 receptor agonists — medicines that activate the same receptors as your natural GLP-1 hormone, just for far longer.

Here's where things get confusing for most people. Semaglutide is the molecule — the active ingredient. But it's sold under different brand names, each approved for a different purpose. Think of it like paracetamol: the same ingredient can appear in Crocin, Dolo, or Calpol, but the packaging, dose, and intended use differ.

Ozempic

Ozempic was the first semaglutide product to gain widespread attention. It's a weekly injection approved for managing Type 2 diabetes. Ozempic helps diabetic patients control blood sugar levels, and many patients also experienced significant weight loss as a side effect — which is partly what kicked off the global conversation.

Wegovy

Wegovy is also a semaglutide injection, but it's specifically approved for chronic weight management. The doses go higher than Ozempic (up to 2.4 mg weekly versus 1 mg for Ozempic), because the goal is different — it's designed to help people with obesity or weight-related health conditions lose a meaningful amount of weight and keep it off.

Rybelsus

Rybelsus is the oral form — a daily tablet. It's currently approved for Type 2 diabetes management. Rybelsus is notable because most GLP-1 medicines are injections, and having a pill option gives patients a choice that some find more convenient.

Key point: All three contain the same molecule, semaglutide. The difference is the dose, the delivery method (injection versus pill), and the condition each one is officially approved to treat.

This is one of the most common sources of confusion. If Ozempic and Wegovy are the same drug, why are they approved for different things?

The answer comes down to clinical trials and regulatory approvals. Before any medicine can be prescribed for a specific condition, it must go through rigorous studies proving it's safe and effective for that condition.

Semaglutide was first studied and approved for diabetes. Researchers noticed that patients were losing substantial weight — not just a kilo or two, but clinically meaningful amounts. So the manufacturer, Novo Nordisk, ran a separate set of large-scale trials (called the STEP trials) specifically testing semaglutide for weight management.

The results were striking. In the STEP 1 trial, participants taking semaglutide 2.4 mg lost an average of about 15% of their body weight over 68 weeks. For someone weighing 100 kg, that's roughly 15 kg — a life-changing amount for many patients with obesity.

Based on these results, regulators approved the higher-dose version (Wegovy) specifically for weight management. So now we have:

• Ozempic / Rybelsus → approved for Type 2 diabetes
• Wegovy → approved for chronic weight management in eligible patients

Same molecule. Different clinical evidence packages. Different approved uses.

Patients often ask: "Can I just take the tablet instead of getting a shot?"

It's a fair question. Here's the context.

The injectable forms (Ozempic, Wegovy) are given once a week using a small, pen-like device. The needle is very thin — most patients describe it as a brief pinch, far less painful than a typical blood test. You inject it into the skin of your abdomen, thigh, or upper arm, and you're done for the week.

The oral form (Rybelsus) is a daily tablet, but it comes with specific instructions: you must take it on an empty stomach, with no more than 120 ml of plain water, and then wait at least 30 minutes before eating, drinking, or taking other medications. This is because the stomach environment needs to be just right for the tablet to be absorbed properly.

In terms of effectiveness, the injectable versions generally deliver more of the drug into your system and have shown stronger results in weight-loss studies. The oral version is effective for blood sugar control in diabetes but is currently approved at lower doses.

Your doctor will help you decide which form makes sense based on your health goals, your medical history, and what's available in your region.

Let's be very clear about something: semaglutide is not a supplement you can buy off a shelf. It's not a protein powder or an herbal extract. It is a prescription medication that must be prescribed and monitored by a licensed doctor.

Why? Several important reasons:

• It affects your hormones and metabolism. GLP-1 receptor agonists change how your body processes food, regulates blood sugar, and signals hunger. These are powerful effects that need medical oversight.
• It has potential side effects. The most common are gastrointestinal — nausea, vomiting, diarrhoea, or constipation, especially when starting or increasing the dose. These are usually manageable but need monitoring.
• It's not safe for everyone. People with a personal or family history of certain thyroid cancers (specifically, medullary thyroid carcinoma), a condition called Multiple Endocrine Neoplasia syndrome type 2, or a history of pancreatitis need careful evaluation before using this medicine — and in some cases, it may be ruled out entirely.
• Dosing must be gradual. Semaglutide is started at a low dose and slowly increased over several weeks. This titration process helps your body adjust and reduces side effects. A doctor manages this schedule.

If you see semaglutide being sold online without a prescription, that's a serious red flag. Unregulated products may be counterfeit, improperly stored, or dosed incorrectly — all of which pose real health risks.

Here's an important note for readers in India: drug approvals vary by country.

A medicine being approved by the US FDA or the European Medicines Agency doesn't automatically mean it's approved for the same use in India. India's Central Drugs Standard Control Organisation (CDSCO) has its own review and approval process.

As of now, certain semaglutide formulations are available in India, but the specific approved indications and available brands may differ from what you read about in international news. Your doctor will know which products are currently approved for use in India and for which conditions.

This is another reason why working with a qualified clinician is essential. A doctor familiar with Indian regulatory approvals can tell you exactly what's available, what's legal, and what's appropriate for your specific situation. Self-prescribing based on international headlines is not just risky — it could mean using a product that isn't authorised for your intended purpose in this country.

The word "breakthrough" gets thrown around a lot in health media. So let's look at why researchers and doctors use it for semaglutide — with actual evidence.

For decades, medical weight-loss options were limited. Older medications produced modest results — typically 3–5% body weight loss — and often came with significant side effects or safety concerns. Bariatric surgery was effective but invasive, expensive, and came with its own risks.

Then came the STEP clinical trial programme — a series of large, well-designed studies involving thousands of participants across multiple countries. Here's what they showed:

• STEP 1: Adults with obesity (without diabetes) lost an average of ~15% body weight over 68 weeks with semaglutide 2.4 mg, compared to ~2.4% with placebo.
• STEP 2: Adults with obesity and Type 2 diabetes lost an average of ~9.6% body weight — still significantly more than previous treatments for this group.
• STEP 3: Combined with intensive behavioural therapy, average weight loss reached ~16%.
• STEP 5: Over two years of continued treatment, weight loss was sustained — showing this wasn't a short-lived effect.

Beyond weight, the SELECT trial demonstrated that semaglutide reduced the risk of major cardiovascular events (heart attack, stroke, or cardiovascular death) by 20% in adults with obesity and established heart disease — even in those without diabetes.

This cardiovascular benefit is what elevated semaglutide from "effective weight-loss drug" to something doctors genuinely consider a breakthrough. It's not just about the number on the scale — it's about reducing the serious health risks that come with obesity.

If you've been reading about semaglutide and wondering whether it might be right for you, here's the honest summary:

• It's a real, well-studied medicine — not a trend or a quick fix.
• It works by mimicking a hormone your body already uses.
• It's available in different forms and for different conditions — your doctor will guide you to the right one.
• It must be prescribed and supervised by a medical professional.
• Eligibility depends on your individual health profile, your medical history, and what's approved in your country.

At Zelta, we believe everyone deserves access to clear, honest information about their health options. If you're curious whether a GLP-1 treatment could be part of your health journey, the best first step is a conversation with a qualified doctor who understands your full picture.

Zelta offers specialist consultations where a licensed clinician reviews your health profile, answers your questions, and helps you understand what options may be appropriate for you — with no pressure and no obligation. A one-time consultation fee applies. If you proceed with a treatment plan, the amount paid is adjusted against the plan price.

This article is for informational and educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any medication, including semaglutide. Drug availability, approved indications, and brand names may vary by country and are subject to change based on regulatory decisions. The clinical trial results cited refer to study averages — individual results vary. Zelta does not encourage self-medication or the purchase of prescription drugs without a valid prescription.